Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A suspicious thought

<Influence a transition to ‘ private’ incorporating with TPL.>

Unless there is some advantage to PTSC shareholders, why would they agree to taking the joint entity private? Where would TPL come up with sufficient cash to make such a thing possible?

Come on now. If you're going to toss out stuff like this, at least put some meat on the bones explaining why it is likely or even possible.

Share
New Message
Please login to post a reply